Vertex Pharmaceuticals (VRTX) Insider Trading
Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Vertex Pharmaceuticals.
Bought (12 mo)
$0
Sold (12 mo)
$158,097,502
Insiders Buying (12 mo)
0
Insiders Selling (12 mo)
13
Form 4 Filings (All Time)
607
Most Recent Purchase
August 7, 2025
Bruce I Sachs
Director
$1,948,415
Most Recent Sale
July 7, 2026
Duncan Mckechnie
EVP
$799,779
Buys (90d)
0
Sells (90d)
0
Recent Insider Transactions
| Filed | Insider | Role | Type | Value | % Change |
|---|---|---|---|---|---|
| 2026-10-22 | Brennan Daniel J. | Director | Award | — | — |
| 2026-10-19 | Garber Alan M | Director | Award | — | — |
| 2026-10-19 | Sachs Bruce I | Director | Award | — | — |
| 2026-09-10 | Van Grunsven Jasper | Officer | Award | — | — |
| 2026-09-01 | Ambrose Kristen | Officer | Award | — | +75.5% |
| 2026-08-31 | Sachs Bruce I | Director | Other | — | -13.3% |
Sign up free to view more insider trades.